首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1729577

日本動物保健市場報告（按動物類型（商業動物、伴侶動物）、產品類型（藥品、生物製劑、藥用飼料添加劑、診斷劑）和地區分類，2025 年至 2033 年

Japan Animal Health Market Report by Animal Type (Commercial, Companions), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本動物保健市場規模達 28.834 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 52.566 億美元，2025-2033 年期間的成長率 (CAGR) 為 6.56%。人畜共通傳染病（可從動物傳播給人類）的日益流行，以及人們對監測和管理動物健康重要性的認知不斷提高，是推動市場發展的主要因素。

動物健康是指家養動物和野生動物的整體健康和身體狀況。它涵蓋了他們的健康的各個方面，包括身體、精神和情緒狀態。保持良好的動物健康對於單一動物的福祉和生態系統的健康至關重要。動物健康涉及預防、診斷和治療可能影響動物的疾病和傷害。這包括為它們提供適當的營養、乾淨的水、住所和適當的獸醫護理。此外，它還包括防止動物疾病傳播的措施，在某些情況下，疾病也會影響人類健康。動物健康至關重要，原因有很多，包括善待和尊重動物的道德責任、牲畜和農業動物的經濟重要性以及野生生物多樣性的保護。監測和促進動物健康對於確保生態系統的永續性以及動物和人類的福祉至關重要。

日本動物保健市場趨勢：

由於多種相互關聯的促進因素，日本的動物保健市場正在經歷強勁成長。首先，該地區民眾對寵物和牲畜健康意識的不斷提高，導致對高品質獸醫產品和服務的需求增加。此外，新興經濟體可支配收入的增加刺激了伴侶動物保健支出的增加，推動了市場擴張。此外，近年來人畜共通傳染病日益突出，凸顯了動物疾病預防和控制的重要性。由於政府和組織認知到動物和人類健康之間的關鍵聯繫，這刺激了對寵物和牲畜的疫苗、診斷和藥物的投資。此外，持續的技術進步促進了精準醫療、遠距醫療和數位健康解決方案等創新產品和治療方法的發展，預計將在預測期內推動日本動物保健市場的發展。

日本動物保健市場細分：

動物類型洞察：

商業的
同伴

產品類型洞察：

製藥
生物製劑
藥用飼料添加劑
診斷

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。一些關鍵參與者包括：

詩華動物保健
禮來動物保健公司
紐勤公司
日本勃林格殷格翰有限公司（Boehringer Ingelheim Auslandsbeteiligungs GmbH）
Vetoquinol日本有限公司
維克
碩騰日本
（請注意，這只是關鍵參與者的部分列表，完整列表在報告中提供。）

本報告回答的關鍵問題：

日本動物保健市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本動物保健市場有何影響？
日本動物保健市場依動物種類如何分類？
根據產品類型，日本動物保健市場是如何分類的？
日本動物保健市場的價值鏈分為哪些階段？
日本動物健康的主要促進因素和挑戰是什麼？
日本動物保健市場的結構是怎麼樣的？主要參與者是誰？
日本動物保健市場的競爭程度如何？

本報告回答的關鍵問題：

日本動物保健市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本動物保健市場有何影響？
日本動物保健市場依動物種類如何分類？
根據產品類型，日本動物保健市場是如何分類的？
日本動物保健市場的價值鏈分為哪些階段？
日本動物健康的主要促進因素和挑戰是什麼？
日本動物保健市場的結構是怎麼樣的？主要參與者是誰？
日本動物保健市場的競爭程度如何？

Japan animal health market size reached USD 2,883.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 5,256.6 Million by 2033, exhibiting a growth rate (CAGR) of 6.56% during 2025-2033. The increasing prevalence of zoonotic diseases, which can be transmitted from animals to humans, along with the rising awareness about the importance of monitoring and managing the health of animals, is primarily driving the market.

Animal health refers to the overall well-being and physical condition of animals, both domestic and wild. It encompasses various aspects of their health, including their physical, mental, and emotional states. Maintaining good animal health is essential for the welfare of individual animals and the health of ecosystems. Animal health involves the prevention, diagnosis, and treatment of diseases and injuries that can affect animals. This includes providing them with proper nutrition, clean water, shelter, and appropriate veterinary care. Additionally, it encompasses measures to prevent the spread of diseases among animals, which can also impact human health in some cases. Animal health is crucial for various reasons, including the ethical responsibility to treat animals with kindness and respect, the economic importance of livestock and agricultural animals, and the preservation of biodiversity in the wild. Monitoring and promoting animal health are vital for ensuring the sustainability of ecosystems and the well-being of both animals and humans.

Japan Animal Health Market Trends:

The animal health market in Japan is experiencing robust growth due to several interconnected drivers. Firstly, the regional population's increasing awareness of pet and livestock well-being has led to a heightened demand for high-quality veterinary products and services. Furthermore, the rise in disposable income on account of emerging economy has spurred greater spending on companion animal health, driving market expansion. Additionally, zoonotic diseases have gained prominence in recent years, underscoring the importance of disease prevention and control in animals. This has stimulated investment in vaccines, diagnostics, and pharmaceuticals for both pets and livestock as governments and organizations recognize the critical link between animal and human health. Moreover, the ongoing technological advancements, which have enabled the development of innovative products and treatments, like precision medicine, telemedicine, and digital health solutions, are expected to drive the animal health market in Japan during the forecast period.

Japan Animal Health Market Segmentation:

Animal Type Insights:

Commercial
Companions

Product Type Insights:

Pharmaceuticals
Biologicals
Medicinal Feed Additives
Diagnostics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

Ceva Animal Health
Elanco Animal Health Incorporated
Neogen Corporation
Nippon Boehringer Ingelheim Co. Ltd. (Boehringer Ingelheim Auslandsbeteiligungs GmbH)
Vetoquinol Japan Co. Ltd.
Virbac
Zoetis Japan
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key Questions Answered in This Report:

How has the Japan animal health market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan animal health market?
What is the breakup of the Japan animal health market on the basis of animal type?
What is the breakup of the Japan animal health market on the basis of product type?
What are the various stages in the value chain of the Japan animal health market?
What are the key driving factors and challenges in the Japan animal health?
What is the structure of the Japan animal health market and who are the key players?
What is the degree of competition in the Japan animal health market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Animal Health Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Animal Health Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Animal Health Market - Breakup by Animal Type

6.1 Commercial
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Companions
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Animal Health Market - Breakup by Product Type

7.1 Pharmaceuticals
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Biologicals
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Medicinal Feed Additives
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Diagnostics
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)

8 Japan Animal Health Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 Ceva Animal Health
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Elanco Animal Health Incorporated
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Neogen Corporation
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Nippon Boehringer Ingelheim Co. Ltd. (Boehringer Ingelheim Auslandsbeteiligungs GmbH)
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
9.5 Vetoquinol Japan Co. Ltd.
- 9.5.1 Business Overview
- 9.5.2 Product Portfolio
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events
9.6 Virbac
- 9.6.1 Business Overview
- 9.6.2 Product Portfolio
- 9.6.3 Business Strategies
- 9.6.4 SWOT Analysis
- 9.6.5 Major News and Events
9.7 Zoetis Japan
- 9.7.1 Business Overview
- 9.7.2 Product Portfolio
- 9.7.3 Business Strategies
- 9.7.4 SWOT Analysis
- 9.7.5 Major News and Events

10 Japan Animal Health Market - Industry Analysis

10.1 Drivers, Restraints and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis